Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03475953 |
Title | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Institut Bergonie |
Indications |
differentiated thyroid gland carcinoma lung non-squamous non-small cell carcinoma |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | FRA |